关注
Ali Rashidfarrokhi
Ali Rashidfarrokhi
Postdoctoral Research Scientist at NYU
在 nyulangone.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity
V Sisirak, B Sally, V d’Agati, W Martinez-Ortiz, ZB Özçakar, J David, ...
Cell 166 (1), 88-101, 2016
4252016
Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation
W Stephenson, LT Donlin, A Butler, C Rozo, B Bracken, A Rashidfarrokhi, ...
Nature communications 9 (1), 791, 2018
3822018
Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA
L Serpas, RWY Chan, P Jiang, M Ni, K Sun, A Rashidfarrokhi, C Soni, ...
Proceedings of the National Academy of Sciences 116 (2), 641-649, 2019
1762019
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
J Hartl, L Serpas, Y Wang, A Rashidfarrokhi, OA Perez, B Sally, V Sisirak, ...
Journal of Experimental Medicine 218 (5), 2021
1002021
Kinetics of adult hematopoietic stem cell differentiation in vivo
S Upadhaya, CM Sawai, E Papalexi, A Rashidfarrokhi, G Jang, ...
Journal of Experimental Medicine 215 (11), 2815-2832, 2018
852018
Generation of immunity against pathogens via single-domain antibody–antigen constructs
JN Duarte, JJ Cragnolini, LK Swee, AM Bilate, J Bader, JR Ingram, ...
The Journal of Immunology 197 (12), 4838-4847, 2016
672016
Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans
FG Tafesse, A Rashidfarrokhi, FI Schmidt, E Freinkman, S Dougan, ...
PLoS pathogens 11 (10), e1005188, 2015
672015
Plasma DNA profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction
RWY Chan, L Serpas, M Ni, S Volpi, LT Hiraki, LS Tam, A Rashidfarrokhi, ...
The American Journal of Human Genetics 107 (5), 882-894, 2020
532020
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
AM Zavitsanou, R Pillai, Y Hao, WL Wu, E Bartnicki, T Karakousi, ...
Cell reports 42 (11), 2023
432023
Sphingomyelin biosynthesis is essential for phagocytic signaling during Mycobacterium tuberculosis host cell entry
P Niekamp, G Guzman, HC Leier, A Rashidfarrokhi, V Richina, F Pott, ...
Mbio 12 (1), 10.1128/mbio. 03141-20, 2021
342021
Quantitative single-cell analysis of signaling pathways activated immediately downstream of histamine receptor subtypes
J Van Unen, A Rashidfarrokhi, E Hoogendoorn, M Postma, TWJ Gadella, ...
Molecular pharmacology 90 (3), 162-176, 2016
242016
Graphene Oxide Nanosheets Modified with Single‐Domain Antibodies for Rapid and Efficient Capture of Cells
GY Chen, Z Li, CS Theile, NM Bardhan, PV Kumar, JN Duarte, ...
Chemistry–A European Journal 21 (48), 17178-17183, 2015
222015
Plasmacytoid dendritic cells are largely dispensable for the pathogenesis of experimental inflammatory bowel disease
CM Sawai, L Serpas, AG Neto, G Jang, A Rashidfarrokhi, R Kolbeck, ...
Frontiers in immunology 9, 2475, 2018
212018
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
R Pillai, SE LeBoeuf, Y Hao, C New, JLE Blum, A Rashidfarrokhi, ...
Science Advances 10 (13), eadm9859, 2024
202024
Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms
KA Lacey, L Serpas, S Makita, Y Wang, A Rashidfarrokhi, C Soni, ...
Journal of Experimental Medicine 220 (6), e20221086, 2023
172023
Visualizing the early stages of phagocytosis
A Rashidfarrokhi, V Richina, FG Tafesse
Journal of Visualized Experiments: JoVE, 54646, 2017
102017
Therapeutic strategies to target tumors with alterations in lkb1 pathway
T Papagiannakopoulos, R Pillai, A Rashidfarrokhi, S Koide, SB Koralov
US Patent App. 18/388,088, 2024
2024
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth
A Rashidfarrokhi, R Pillai, Y Hao, WL Wu, B Karadal-Ferrena, ...
bioRxiv, 2023.07. 15.549147, 2023
2023
LKB1-LIF Signaling Axis Promotes an Immunosuppressive Microenvironment in Lung Adenocarcinoma
R Pillai, A Rashidfarrokhi, Y Hao, KK Wong, S Koide, A Tsirigos, ...
D98. UPDATE ON THE" OMICS" OF LUNG CANCER: A TRANSLATIONAL SESSION, A6603-A6603, 2023
2023
Glutamine antagonist DRP-104 enhances anti-tumor responses in KEAP1 mutant lung cancer
R Pillai, S LeBoeuf, A Rashidfarrokhi, SM Huang, T Karakousi, ...
Cancer Research 83 (7_Supplement), 4904-4904, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20